ZeptoLink IOL positioning system receives FDA 510(k) clearance
Click Here to Manage Email Alerts
Key takeaways:
- The FDA cleared the ZeptoLink IOL positioning system.
- A phased U.S. market rollout will begin after the American Society of Cataract and Refractive Surgery meeting.
Centricity Vision received 510(k) clearance from the FDA for the ZeptoLink IOL positioning system, according to a press release.
ZeptoLink, which can be integrated with any phacoemulsification system, uses “suction and irrigation provided by the phaco system, enabling surgeons to fully control the Zepto handpiece apposition, suction, energy delivery and release using the phaco foot pedal,” the release said.
Additionally, it offers improved outcomes by allowing surgeons to center the capsulotomy with 360° IOL overlap on the patient’s visual axis by applying 12 micropulses of energy in 4 milliseconds.
Centricity plans to introduce ZeptoLink at the American Society of Cataract and Refractive Surgery meeting, followed by a phased U.S. market rollout and a broader commercial launch later this year.
“By improving IOL centration and operating room productivity, ZeptoLink will benefit patients and practices alike,” Rob Thornhill, president and CEO of Centricity Vision, said in the release. “We believe this streamlined surgical solution will help drive the future of automated refractive cataract surgery.”
Read more about
Click Here to Manage Email Alerts